Putting patients at the centre of the EU health and pharmaceutical agenda
The COVID-19 crisis exposed the vulnerabilities of national healthcare systems and highlighted the importance of health policies that truly address
Read more
Health
Getting the message across: A path to a healthy future for Europe
While Europe wrestles with pressing questions over its health strategy following the end of the COVID-19 public health emergency, practical
Read more
Policy priorities to prepare for the next health crisis – including building more resilient medical supply chains
With 7million reported COVID-19 deaths and over 19 million excess deaths estimated worldwide by January 2023, COVID-19 brought to the
Read more
Health security strategy: strengthening Europe’s pharma industry base
A resilient and dynamic ecosystem for healthcare innovation is key to strengthening the European Union. A comprehensive strategy brings patient
Read more
Enhancing the resilience and the competitiveness of the pharma supply chains to secure access to critical medicines and other medical countermeasures
When the COVID-19 pandemic hit, countries around the globe were caught off guard. In Europe, each country initially responded on
Read more
The value of investing in Advanced Therapy Medicinal Products: combining sustainability, innovation and respect for patients’ rights
To move towards the European Health Union, we probably also need to go beyond the current narrative concerning the European
Read more
An EU Immunisation Strategy: making Europe more resilient
Vaccination is critical to our health security infrastructure, laying the foundation for a more innovative, healthier, prosperous Europe, writes Sibilia
Read more
The patient at the center of all health policies
In the wake of the global COVID-19 crisis, Europe stands at a critical juncture in shaping its health policies and
Read more